Drug
Dectrekumab clinical trials
Also written QAX576.
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
- QAX576
- 12
Studies by the year they started
12 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses dectrekumab is read from its arms, and is right about nine times in ten.
Testing it · 12
- Efficacy and Safety of QAX576 in Patients With Eosinophilic EsophagitisCompletedPhase 2Novartis PharmaceuticalsNCT01022970Written as QAX576
- To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With AsthmaCompletedPhase 1Novartis PharmaceuticalsNCT01568762Written as QAX576
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma PatientsCompletedPhase 1/2Novartis PharmaceuticalsNCT00940160Written as QAX576
- Efficacy of QAX576 in AsthmaCompletedPhase 2Novartis PharmaceuticalsNCT01130064Written as QAX576
- SD, IL-13 Production Rate in IPFCompletedPhase 2Novartis PharmaceuticalsNCT00532233Written as QAX576
- Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)TerminatedPhase 2Novartis PharmaceuticalsNCT01266135Written as QAX576
- Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid RecurrenceTerminatedPhase 2Novartis PharmaceuticalsNCT00987545Written as QAX576
- QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic SclerosisTerminatedPhase 2Novartis PharmaceuticalsNCT00581997Written as QAX576
- An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated HayfeverCompletedPhase 2NovartisNCT00584584Written as QAX576
- A Phase II Efficacy Study in Fistulizing Crohn's Disease PatientsCompletedPhase 2Novartis PharmaceuticalsNCT01355614Written as QAX576
- Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic AsthmaWithdrawnPhase 1/2NovartisNCT00598104Written as QAX576
- Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.CompletedPhase 1NovartisNCT00417196Written as QAX576
Codes
What other systems call dectrekumab · ClinicalTrials.gg INT015409
- UNII (FDA) 764HZ2554DDECTREKUMABConfirmed FDA, Wikidata
- Wikidata Q27282799dectrekumabConfirmed FDA, Wikidata
- NCI Thesaurus C166997DectrekumabOne source FDA
- DrugBank DB14789One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 764HZ2554D | DECTREKUMAB | Confirmed FDA, Wikidata |
| Wikidata | Q27282799 | dectrekumab | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166997 | Dectrekumab | One source FDA |
| DrugBank | DB14789 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.